Re:At $75K, housing a prisoner in California now costs more ...
by refurb on Friday March 22, 2019 @09:01AM
(#19462094)
That’s just the legacy of acquisitions. A lot of Roche’s revenue (40%) comes from Genentech, an American company they acquired 10 years ago.
Re:At $75K, housing a prisoner in California now costs more ...
by coldtea on Friday March 22, 2019 @06:19AM
(#19461068)
How is this relevant? 2 and 4 can still have most of their revenues from where 1 and 3 have them (e.g. not by blood-sucking the Swiss society).
Re:At $75K, housing a prisoner in California now costs more ...
by dagw on Friday March 22, 2019 @07:25AM
(#19461485)
The US accounts for roughly 50% of Roche pharmaceutical revenue, so pretty much.
Re:At $75K, housing a prisoner in California now costs more ...
by benj111 on Friday March 22, 2019 @06:28AM
(#19461121)
They don't sell just in Switzerland though, they sell worldwide, most of their money is probably made in the US.
Re:At $75K, housing a prisoner in California now costs more ...
by dagw on Friday March 22, 2019 @07:07AM
(#19461349)
A lot of J&J's revenue comes from non-pharmaceutical businesses. If you rank by pharmaceutical R&D spending instead Roche comes out ahead of J&J. If you rank by revenue from pharmaceutical sales Pfizer is nr 1 with Novartis and Roche 2 & 3
Rank Company 2016 USD billions
1 Johnson & Johnson NYSE: JNJ 71.89
2 Roche SIX: ROG 50.11
3 Pfizer NYSE: PFE 52.82
4 Novartis NYSE: NVS 48.52
Number 2 and Number 4 are swiss companies.